Banner of CND: United Nations Commission on Narcotic Drugs, policymaking body of the United Nations system with prime responsibility for drug-related matters

Drug-related resolutions and decisions 2020 to 2029

The resolutions and decisions database offers for full text search and sorting:

  

  

 

2021

All languages

Arabic Chinese English French RussianSpanish 

ECOSOC

Decision 2021/220

Report of the Commission on Narcotic Drugs on its reconvened sixty-third session

Decision 20021/251

Report of the Commission on Narcotic Drugs on its sixty-fourth session and provisional agenda of its sixty-fifth session

CND

Resolution 64/1

Statement of the Commission on Narcotic Drugs on the impact of the coronavirus disease (COVID-19) pandemic on the implementation of Member States’ joint commitments to address and counter all aspects of the world drug problem

Resolution 64/2

Promoting alternative development as a development-oriented drug control strategy, including in the context of the coronavirus disease (COVID-19) pandemic and its consequences

Resolution 64/3

Promoting scientific evidence-based, quality, affordable and comprehensive drug prevention, treatment, sustained recovery and related support services

Resolution 64/4

Improving data collection on, and responses to, the harmful effects of the non-medical use of pharmaceuticals containing narcotic drugs, psychotropic substances or new psychoactive substances

Resolution 64/5

Facilitating access to comprehensive, scientific evidence-based drug demand reduction services and related measures, including for people impacted by social marginalization

Decision 64/1

Inclusion of isotonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

Decision 64/2

Inclusion of CUMYL-PEGACLONE in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 64/3

Inclusion of MDMB-4en-PINACA in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 64/4

Inclusion of 3-methoxyphencyclidine in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 64/5

Inclusion of diphenidine in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 64/6

Inclusion of clonazolam in Schedule IV of the Convention on Psychotropic Substances of 1971

Decision 64/7

Inclusion of diclazepam in Schedule IV of the Convention on Psychotropic Substances of 1971

Decision 64/8

Inclusion of flubromazolam in Schedule IV of the Convention on Psychotropic Substances of 1971

2020 

All languages

Arabic Chinese English French RussianSpanish 

General Assembly

A/RES/75/198

International cooperation to address and counter the world drug problem

ECOSOC

Decision 2020/213

Report of the Commission on Narcotic Drugs on its reconvened sixty-second session

Decision 2020/2014

Report of the Commission on Narcotic Drugs on its sixty-third session and provisional agenda for its sixty-fourth session

Decision 2020/2015

Report of the International Narcotic Control Board

CND

Resolution 63/1

Promoting efforts by Member States to address and counter the world drug problem, in particular supply reduction-related measures, through effective partnerships with private sector entities

Resolution 63/2

Promoting and improving the collection and analysis of reliable and comparable data to strengthen balanced, integrated, comprehensive, multidisciplinary and scientific evidence-based responses to the world drug problem

Resolution 63/3

Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of internationally controlled substances for medical and scientific purposes and improving their rational use

Resolution 63/4

Promoting the involvement of youth in drug prevention efforts

Resolution 63/5

Promoting alternative development as a development-oriented drug control strategy

Decision 63/1

Inclusion of methyl alpha-phenylacetoacetate (MAPA), including its optical isomers, in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988

Decision 63/2

Inclusion of crotonylfentanyl in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

Decision 63/3

Inclusion of valerylfentanyl in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

Decision 63/4

Inclusion of DOC in Schedule I of the of the Convention on Psychotropic Substances of 1971

Decision 63/5

Inclusion of AB-FUBINACA in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/6

Inclusion of 5F-AMB-PINACA (5F-AMB, 5F-MMB-PINACA) in Schedule II of the Convention on Psychotropic Substances of 1971    

Decision 63/7

Inclusion of 5F-MDMB-PICA (5F-MDMB-2201) in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/8

Inclusion of 4F-MDMB-BINACA in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/9

Inclusion of 4-CMC (4-chloromethcathinone, clephedrone) in Schedule II of the Convention on Psychotropic Substances of 1971  

Decision 63/10

Inclusion of N-ethylhexedrone in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/11

Inclusion of alpha-PHP in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/12

Inclusion of flualprazolam in Schedule IV of the Convention on Psychotropic Substances of 1971

Decision 63/13

Inclusion of etizolam in Schedule IV of the Convention on Psychotropic Substances of 1971

Decision 63/14

Changes in the scope of control of substances: proposed scheduling recommendations by the World Health Organization on cannabis and cannabis-related substances

Decision 63/15

Improved and streamlined annual report questionnaire